ID   SP2/0 MP
AC   CVCL_F1LE
RX   PubMed=15345310;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Control cell line for SP2/0 mIL-6 A9 (Cellosaurus=CVCL_F1LD) (PubMed=15345310).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
RX   PubMed=15345310; DOI=10.1016/j.jim.2004.05.005;
RA   Dessain, Scott K.
RA   Adekar, Sharad P.
RA   Stevens, Jennifer B.
RA   Carpenter, Katherine A.
RA   Skorski, Maria Leilani
RA   Barnoski, Barry L.
RA   Goldsby, Richard A.
RA   Weinberg, Robert Allan
RT   "High efficiency creation of human monoclonal antibody-producing
RT   hybridomas.";
RL   J. Immunol. Methods 291:109-122(2004).
//